Abstract
This study reviews the available Indian literature on buprenorphine abuse. Buprenorphine was introduced in 1986; the abuse, first noticed in 1987, increased rapidly till 1994, and then decreased gradually. Initiated through other addicts and medical practitioners, the abuse was mostly as a cheap, easily and legally available substitute for opioids. The typical young adult male abuser used an intravenous cocktail with diazepam, pheneramine or promethazine for a better kick. The withdrawal syndrome was typical of the opioids and without an expected delayed onset. Complications of pseudoaneurysm and recurrent koro in repeated withdrawal were reported. Buprenorphine as a detoxifying agent for opioids reportedly gave better symptom control in the first week but high rates of dependence induction were reported. The Indian data tends to caution against the Western enthusiasm to use buprenorphine for detoxification or maintenance of opioid abusers.
Keywords: Buprenorphine, substance abuse, India
Full Text
The Full Text of this article is available as a PDF (230.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Banks C. D. Overdosage of buprenorphine: case report. N Z Med J. 1979 Apr 11;89(633):255–257. [PubMed] [Google Scholar]
- Basu D., Mattoo S. K., Arora A., Malhotra A., Varma V. K. Pseudoaneurysm in injecting drug abusers: cases from India. Addiction. 1994 Dec;89(12):1697–1699. doi: 10.1111/j.1360-0443.1994.tb03771.x. [DOI] [PubMed] [Google Scholar]
- Cheskin L. J., Fudala P. J., Johnson R. E. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug Alcohol Depend. 1994 Oct;36(2):115–121. doi: 10.1016/0376-8716(94)90093-0. [DOI] [PubMed] [Google Scholar]
- Hammersley R., Lavelle T., Forsyth A. Buprenorphine and temazepam--abuse. Br J Addict. 1990 Feb;85(2):301–303. doi: 10.1111/j.1360-0443.1990.tb03088.x. [DOI] [PubMed] [Google Scholar]
- Harper I. Temgesic abuse. N Z Med J. 1983 Oct 12;96(741):777–777. [PubMed] [Google Scholar]
- Janiri L., Mannelli P., Persico A. M., Serretti A., Tempesta E. Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine. Drug Alcohol Depend. 1994 Oct;36(2):139–145. doi: 10.1016/0376-8716(94)90096-5. [DOI] [PubMed] [Google Scholar]
- Jasinski D. R., Pevnick J. S., Griffith J. D. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psychiatry. 1978 Apr;35(4):501–516. doi: 10.1001/archpsyc.1978.01770280111012. [DOI] [PubMed] [Google Scholar]
- Ling W., Wesson D. R., Charuvastra C., Klett C. J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry. 1996 May;53(5):401–407. doi: 10.1001/archpsyc.1996.01830050035005. [DOI] [PubMed] [Google Scholar]
- Malhotra A., Balaji M., Basu D., Mattoo S. K., Varma V. K., Sehgal S. HIV screening & risk behaviour in psychoactive substance users. Indian J Med Res. 1993 Nov;97:231–233. [PubMed] [Google Scholar]
- Mello N. K., Mendelson J. H. Buprenorphine suppresses heroin use by heroin addicts. Science. 1980 Feb 8;207(4431):657–659. doi: 10.1126/science.7352279. [DOI] [PubMed] [Google Scholar]
- Nigam A. K., Ray R., Tripathi B. M. Buprenorphine in opiate withdrawal: a comparison with clonidine. J Subst Abuse Treat. 1993 Jul-Aug;10(4):391–394. doi: 10.1016/0740-5472(93)90024-v. [DOI] [PubMed] [Google Scholar]
- Nigam A. K., Srivastava R. P., Saxena S., Chavan B. S., Sundaram K. R. Naloxone-induced withdrawal in patients with buprenorphine dependence. Addiction. 1994 Mar;89(3):317–320. doi: 10.1111/j.1360-0443.1994.tb00898.x. [DOI] [PubMed] [Google Scholar]
- O'Connor J. J., Moloney E., Travers R., Campbell A. Buprenorphine abuse among opiate addicts. Br J Addict. 1988 Sep;83(9):1085–1087. doi: 10.1111/j.1360-0443.1988.tb00536.x. [DOI] [PubMed] [Google Scholar]
- San L., Camí J., Fernández T., Ollé J. M., Peri J. M., Torrens M. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects. Br J Addict. 1992 Jan;87(1):55–62. doi: 10.1111/j.1360-0443.1992.tb01900.x. [DOI] [PubMed] [Google Scholar]
- Stark C., Sykes R., Mullin P. Temazepam abuse. Lancet. 1987 Oct 3;2(8562):802–803. doi: 10.1016/s0140-6736(87)92539-6. [DOI] [PubMed] [Google Scholar]
- Strang J. Abuse of buprenorphine. Lancet. 1985 Sep 28;2(8457):725–725. doi: 10.1016/s0140-6736(85)92961-7. [DOI] [PubMed] [Google Scholar]
- Walsh S. L., Preston K. L., Stitzer M. L., Cone E. J., Bigelow G. E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther. 1994 May;55(5):569–580. doi: 10.1038/clpt.1994.71. [DOI] [PubMed] [Google Scholar]